GlassScriptPhysician profile
Kerri A Simo
NPI 1700096088
$9,815.19
in general payments reported to CMS, 2019-2025
25 companies · $2,748 in 2025
The $2,748 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $187 · 2021: $631 · 2022: $997 · 2023: $2,764 · 2024: $1,136 · 2025: $2,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,111 · Food and Beverage: $2,037 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,111.36 |
| Food and Beverage | $2,036.52 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,830.99 | 2021-2023 | Nanoknife, Angiovac, Alphavac |
| Intuitive Surgical, INC. | $2,579.63 | 2019-2025 | |
| Histosonics, INC. | $1,397.92 | 2025 | |
| Abbvie INC. | $1,156.53 | 2019-2025 | Creon, Linzess |
| Medtronic, INC. | $329.70 | 2021-2024 | Signia |
| Alcresta Therapeutics, INC. | $210.37 | 2019-2024 | Relizorb |
| Inari Medical, INC. | $206.04 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Nestle Healthcare Nutrition INC. | $171.26 | 2021-2023 | |
| Misonix INC | $135.09 | 2020 | |
| Merck Sharp & Dohme LLC | $105.67 | 2019 | |
| Haemonetics Corporation | $99.89 | 2022 | |
| Stryker Corporation | $90.27 | 2024 | 1788, N/A |
| Novartis Pharmaceuticals Corporation | $71.55 | 2021-2022 | |
| Boston Scientific Corporation | $68.54 | 2024 | Spyglass |
| Exelixis INC. | $63.11 | 2021-2023 | Cabometyx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Healthmyne, INC. | $62.53 | 2019 | |
| Aimmune Therapeutics, INC. | $55.59 | 2024-2025 | Zenpep |
| Vivus LLC | $53.19 | 2021-2022 | |
| Covidien LP | $34.36 | 2019 | |
| Exact Sciences Corporation | $29.56 | 2023 | |
| Ethicon US, LLC | $17.52 | 2024 | Neuwave |
| Shionogi INC | $16.89 | 2019 | |
| Kci USA, INC. | $15.72 | 2021 | |
| Dilon Technologies, INC. | $13.27 | 2023 | Hemoblast Bellows |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerri Simo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.